Does Dr. HAYDER AHMED have financial conflicts of interest?

Dr. HAYDER AHMED (M.D.) has received a total of $684 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $684 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. HAYDER AHMED?

According to CMS Open Payments data, Dr. HAYDER AHMED received funding from JANSSEN PHARMACEUTICALS ($115), NOVARTIS PHARMACEUTICALS CORPORATION ($92), and BOSTON SCIENTIFIC CORPORATION ($71).

Does Dr. HAYDER AHMED receive research grants or speaking fees?

Dr. HAYDER AHMED has received $684 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. HAYDER AHMED

M.D.Real-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: FRENCH CAMP, CA 95231

NPI Number: 1588927222

LIFETIME INDUSTRY VALUE

$684

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AHMED is a verified Internal Medicine, Cardiovascular Disease practitioner based in FRENCH CAMP, CA.

Between 2021 and 2024, Dr. AHMED had an overall industry promotional and research financial footprint of $684 as recorded in the federal CMS Open Payments database.

$684 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AHMED's primary funding source is JANSSEN PHARMACEUTICALS, which accounts for $115 (representing 16.8% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN PHARMACEUTICALS

Rank 1

$115

16.8%

NOVARTIS PHARMACEUTICALS CORPORATION

Rank 2

$92

13.5%

BOSTON SCIENTIFIC CORPORATION

Rank 3

$71

10.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.